Category: Viruses & Health

Spain has recorded 141 cases of West Nile virus that were acquired within the country as of mid-October 2026. These locally transmitted infections represent the cumulative total for the year so far.

West Nile virus continues to be a public health concern in Spain, with transmission occurring within the country’s borders. Additional information about the virus, its symptoms, transmission methods, and prevention measures is available in detailed reference materials on the topic.

Source: Read the full story at TravelHealthPro

This summary was written with AI assistance from the linked source.

Researchers have identified a natural compound called argyrin B that can effectively eliminate Clostridioides difficile, a dangerous bacterium responsible for severe gut infections, while preserving beneficial microorganisms. The compound showed strong antibacterial activity in laboratory tests and mouse experiments, with minimal impact on helpful gut bacteria. Scientists discovered that argyrin B, originally found in soil-dwelling microorganisms, targets a specific mechanism that the pathogenic bacteria depend on for survival.

A key advantage of argyrin B is that when taken orally, it remains concentrated in the large intestine where C. difficile infections occur rather than entering the bloodstream, potentially reducing side effects in other organs. Researchers must conduct further studies to determine appropriate dosages and confirm the compound’s safety for human use. If proven effective in clinical settings, this targeted treatment could help patients avoid recurrent infections and potentially reduce the need for fecal microbiota transplants, a more invasive procedure currently used for repeat infections.

Source: Read the full story at ScienceDaily

This summary was written with AI assistance from the linked source.

Kenya has confirmed seven additional Ebola cases among individuals who had contact with a man who traveled from the Democratic Republic of Congo to Kenya in early October and subsequently died. This brings Kenya’s total to eight confirmed cases. The newly identified patient is a 49-year-old caregiver who was already in quarantine. Healthcare workers and a family member of the initial patient are among those infected. Kenyan health officials report no evidence of community transmission at this time, with 128 of 130 known contacts currently quarantined for a 21-day monitoring period.

The Democratic Republic of Congo continues to experience a severe outbreak centered in Ituri province, with the virus now affecting eight provinces. As of the weekend, officials reported 9,455 confirmed cases and 4,561 deaths, resulting in a fatality rate of 48.2%. A significant concern is the disproportionate impact on children, who comprise 24% of new patients. However, treatment centers lack adequate resources for pediatric care, and children have limited access to experimental vaccines and new therapeutic options, prompting medical organizations to call for their inclusion in vaccine trials.

Source: Read the full story at CIDRAP

This summary was written with AI assistance from the linked source.

Researchers at the University of Cambridge tested 39 sweeteners against 25 species of gut bacteria in laboratory experiments and found that approximately three-quarters of the sweeteners altered the growth of at least one bacterial species. Some sweeteners slowed or stopped the growth of microbes associated with digestive health. The findings were published in Molecular Systems Biology, though scientists emphasized that these experiments occurred in laboratory settings rather than in human bodies, and further research is needed to determine real-world health implications.

The study also examined how sweeteners interact with common medications and substances. Researchers discovered over 100 instances where a sweetener’s effect on bacteria changed when combined with other compounds. Notably, the sweetener isosteviol paired with the antidepressant duloxetine strongly suppressed two important gut bacteria involved in digestive health and blood sugar regulation, and altered the diversity of a simulated gut microbiome. The findings challenge the assumption that sweeteners are metabolically neutral and highlight the importance of studying how everyday combinations of ingredients and medications interact within the digestive system.

Source: Read the full story at ScienceDaily

This summary was written with AI assistance from the linked source.

Researchers at Michigan Medicine have developed an experimental drug called DT-109 that reversed severe fatty liver disease in animal studies by targeting the gut rather than the liver directly. The compound works by reducing harmful gut bacteria, strengthening the intestinal lining, and preventing inflammatory substances from entering the liver. The findings, published in The Journal of Clinical Investigation, demonstrate a new approach to treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease affecting approximately 7% of the global population.

MASH causes excess fat accumulation in the liver, leading to inflammation and cellular damage that can progress to cirrhosis, liver cancer, and liver failure. The research revealed that DT-109 interrupts a damaging cycle by reducing levels of harmful bacteria that produce ammonia, which weakens the gut’s protective barrier and allows toxins to reach the liver. While results in mice and nonhuman primates were encouraging, the drug remains experimental and has not yet been tested in humans. Researchers plan further evaluation with the goal of advancing DT-109 toward clinical trials to determine its safety and effectiveness in patients.

Source: Read the full story at ScienceDaily

This summary was written with AI assistance from the linked source.

Washington state officials confirmed a human case of H5N1 avian flu in a resident exposed to infected dairy cows in Yakima County. The infected person is not seriously ill and is isolating at home. This detection follows the state’s first identification of H5N1 in dairy cattle at two local farms the previous week. Health authorities stated that the risk of avian flu transmission to the general public remains low.

Florida reported 72 additional locally acquired dengue fever cases, bringing the yearly total to 368 through October 10, marking the largest U.S. dengue outbreak in recent decades. The outbreak spans eight counties, with Hillsborough County accounting for most cases at 310, though Pinellas County cases are rising at 37. Meanwhile, Madagascar confirmed four plague cases across four districts since late July, with five additional suspected cases identified the following week. Authorities treated approximately 200 patient contacts preventively and launched flea spraying and public awareness campaigns.

Source: Read the full story at CIDRAP

This summary was written with AI assistance from the linked source.

France has documented 178 cases of West Nile virus acquired within the country as of mid-October 2026. The infections have been identified across eight regions, including Provence-Alpes-Côte d’Azur, Occitanie, Île-de-France, Auvergne-Rhône-Alpes, Nouvelle-Aquitaine, Pays de la Loire, Centre-Val de Loire, and Corsica.

This outbreak represents a significant spread of the virus throughout multiple parts of the country during 2026. The cases are classified as locally-acquired, indicating transmission occurring within France rather than imported from elsewhere.

Source: Read the full story at TravelHealthPro

This summary was written with AI assistance from the linked source.

The World Health Organization’s advisory group on immunization has determined that a single dose of the human papillomavirus vaccine is now the most effective strategy for preventing cervical cancer. The recommendation marks a shift from previous guidance, as persistent HPV infection can cause multiple cancer types, with cervical cancer being the fifth most commonly diagnosed cancer among women. The vaccine prevents approximately 90 percent of these cancers from developing.

Under the new guidelines, girls aged 9 to 14 years should receive one HPV vaccine dose, though younger girls starting at age 4 may be vaccinated to improve coverage rates. The single-dose schedule can also be extended to unvaccinated women up to age 30 and boys through age 20, with women aged 25 and younger prioritized. Those who are immunocompromised, including people with well-controlled HIV, should continue receiving two doses, while severely immunocompromised individuals require three doses. The updated recommendations aim to help the WHO reach its goal of 90 percent global HPV vaccination coverage, currently at 33 percent.

Source: Read the full story at CIDRAP

This summary was written with AI assistance from the linked source.